Henry Schein, Inc. (NASDAQ:HSIC) Shares Purchased by Linden Thomas Advisory Services LLC

Linden Thomas Advisory Services LLC boosted its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 10.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,345 shares of the company’s stock after acquiring an additional 760 shares during the period. Linden Thomas Advisory Services LLC’s holdings in Henry Schein were worth $632,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. Lazard Asset Management LLC increased its holdings in shares of Henry Schein by 1,303.3% in the third quarter. Lazard Asset Management LLC now owns 1,247,334 shares of the company’s stock valued at $92,614,000 after purchasing an additional 1,158,451 shares during the last quarter. Boston Partners boosted its position in shares of Henry Schein by 4,975.9% during the 3rd quarter. Boston Partners now owns 1,080,598 shares of the company’s stock valued at $80,229,000 after acquiring an additional 1,059,309 shares during the last quarter. American Century Companies Inc. increased its position in Henry Schein by 7.3% during the third quarter. American Century Companies Inc. now owns 4,719,088 shares of the company’s stock worth $350,392,000 after purchasing an additional 322,649 shares during the last quarter. Artisan Partners Limited Partnership purchased a new position in Henry Schein during the third quarter worth about $19,864,000. Finally, Adage Capital Partners GP L.L.C. acquired a new position in Henry Schein in the 3rd quarter valued at about $16,650,000. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently commented on HSIC shares. Evercore ISI upped their price objective on Henry Schein from $79.00 to $83.00 and gave the company an “in-line” rating in a report on Wednesday, February 28th. Jefferies Financial Group lifted their price target on shares of Henry Schein from $74.00 to $81.00 and gave the company a “hold” rating in a research report on Wednesday, March 6th. Leerink Partnrs restated a “market perform” rating on shares of Henry Schein in a report on Monday, February 26th. Barrington Research lifted their target price on shares of Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a report on Wednesday, February 28th. Finally, TheStreet upgraded Henry Schein from a “c+” rating to a “b-” rating in a research report on Monday, February 26th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $81.09.

Henry Schein Trading Down 0.5 %

NASDAQ:HSIC opened at $72.82 on Friday. Henry Schein, Inc. has a 12-month low of $60.01 and a 12-month high of $83.15. The firm has a market cap of $9.36 billion, a PE ratio of 23.12, a price-to-earnings-growth ratio of 1.81 and a beta of 0.87. The company has a current ratio of 1.67, a quick ratio of 1.00 and a debt-to-equity ratio of 0.45. The stock has a fifty day moving average price of $74.28 and a 200 day moving average price of $72.43.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, February 27th. The company reported $0.66 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.70 by ($0.04). Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The company had revenue of $3.02 billion during the quarter, compared to analysts’ expectations of $3 billion. During the same quarter in the previous year, the business posted $1.21 EPS. The business’s quarterly revenue was down 10.5% compared to the same quarter last year. Sell-side analysts anticipate that Henry Schein, Inc. will post 5.07 earnings per share for the current fiscal year.

Insider Buying and Selling at Henry Schein

In other news, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction on Monday, March 18th. The shares were sold at an average price of $74.37, for a total transaction of $216,193.59. Following the completion of the sale, the insider now directly owns 209,562 shares of the company’s stock, valued at approximately $15,585,125.94. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other Henry Schein news, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $74.37, for a total transaction of $216,193.59. Following the completion of the sale, the insider now directly owns 209,562 shares of the company’s stock, valued at approximately $15,585,125.94. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Bradford C. Connett sold 6,430 shares of the firm’s stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the sale, the chief executive officer now directly owns 73,108 shares in the company, valued at approximately $5,430,462.24. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.